Renal manifestations of the metabolic syndrome

Nephrology Dialysis Transplantation

Volumn 20, Issue 5, 2005, Pages 861-864

  Tuttle, Katherine R ^a  

^a SACRED HEART MEDICAL CENTER   (United States)

Author keywords

Diabetic glomerulopathy; Glomerular filtration rate; Microalbuminuria; Nutrition; Obesity

Indexed keywords

AMINO ACID DERIVATIVE; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE;

BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; DYSLIPIDEMIA; EDITORIAL; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HYPERINSULINEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; KIDNEY BLOOD FLOW; KIDNEY PLASMA FLOW; METABOLIC SYNDROME X; MICROALBUMINURIA; NONHUMAN; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT;

ANIMALS; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; METABOLIC SYNDROME X; RISK FACTORS;

EID: 18944394952     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh767     Document Type: Editorial

References (30)

1. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, for the conference participants. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438
2. Anavekar NS, McMurray JV, Velaquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295
3. Dineen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. Arch Intern Med 1997; 157: 1413-1418
4. Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
6. Hillege HL, Fidler V, Diercks GF et al. Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782
7. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35: 898-903
8. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167-174
9. Jones CA, Francis ME, Eberhardt MS et al. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002; 39: 445-459
10. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 2003; 16: 952-958
11. Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001; 103: 1869-1874
12. Tuttle KR, Puhlman ME, Cooney SK, Short RA. Urinary albumin and insulin as predictors of coronary artery disease: an angiographic study. Am J Kidney Dis 1999; 34: 918-925
13. Hoehner CM, Greenlund KJ, Rith-Najarian S, Casper ML, McClellan WM. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol 2002; 13: 1626-1634
14. Hoy WE, Mathews JD, McCredie DA et al. The multi-dimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int 1998; 54: 1296-1304
15. Meigs JB, D'Agostino RB,Sr, Nathan DM, Rifai N, Wilson PW; Framingham Offspring Study. Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study. Diabetes Care 2002; 25: 977-983
16. Segura J, Campo C, Roldan C et al. Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbances. J Am Soc Nephrol 2004; 15: S37-S42
17. Salmennienmi U, Ruotsalainen E, Pihlajamäki J et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 2004; 110: 3842-3848
18. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509
19. Adelman RD, Restaino IG, Alon US, Blowey DL. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 2001; 138: 481-485
20. Cohen AH. Massive obesity and the kidney. A morphologic and statistical study. Am J Pathol 1975; 81: 117-130
21. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000; 278: F817-F822
22. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Yaacov O. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14: 1480-1486
23. Tuttle KR, Bruton JL. Effect of insulin therapy on renal hemodynamic response to amino acids and renal hypertrophy in non-insulin dependent diabetes. Kidney Int 1992; 42: 167-173
24. Tuttle KR, Bruton JL, Perusek M, Lancaster JL, Kopp DT, DeFronzo RA. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 1991; 324: 1626-1632
25. Tuttle KR, Puhlman ME, Cooney SK, Short RA. Effects of amino acids and glucagon on renal hemodynamics in type 1 diabetes. Am J Physiol 2002; 282: F103-F112
26. Kasiske BL, O'Donnell MP, Keane WF. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 1992; 19: I110-I115
27. Chua SC, White DW, Wu-Peng S et al. Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr). Diabetes 1996; 45: 1141-1143
28. Maddox DA, Alavi FK, Santella RN, Zawada ET, Jr. Prevention of obesity-linked renal disease: age-dependent effects of dietary food restriction. Kidney Int 2002; 62: 208-219
29. Meek RL, Cooney SK, Flynn SD et al. Amino acids induce indicators of response to injury in glomerular mesangial cells. Am J Physiol 2003; 285: F79-F86
30. Tuttle KR, Johnson EC, Cooney SK et al. Amino acids injure mesangial cells by advanced glycation end products, oxidative stress, and protein kinase C. Kidney Int 2005 (in press)